Precision medicine relies on biomarker testing to match therapies to specific cancers, yet many patients remain untested due ...

The landscape of oncology is undergoing a transformative shift with the emergence of tumor-agnostic approaches, driven by the understanding that cancer treatment can transcend the traditional paradigm ...

This collection examines the critical role of biomarkers in clinical trials in breast cancer and their impact on personalized medicine. It covers predictive and prognostic biomarkers that guide ...

While it can help with early detection and targeted treatment for Alzheimer's disease, multiple sclerosis and more, it is particularly impactful for cancer patients. Timing is everything when it comes ...

Global prevalence estimates show Alzheimer’s disease accounts for most dementia, with ~57 million people affected in 2021 and numbers projected to triple by 2050. People and health systems face rising ...

High biomarker levels, low treatment response One especially meaningful molecule was a cell division protein called Ki67, which is produced at elevated levels when T helper cells divide. Patients with ...

Frequency of surveillance CT scan ordering in patients with stage II/III colorectal cancer. Real-world genomic testing performance in colorectal cancer (CRC): The MultiTEAM Systems Framework Precision ...

Circulating tumor DNA (ctDNA) assays are promising tools for the prediction of cancer treatment response. Here, we build a framework for the design of ctDNA biomarkers of therapy response that ...

BOSTON--(BUSINESS WIRE)--Genialis, the RNA biomarker company, today announced an extension of its collaboration with Debiopharm, a Swiss-based global biopharmaceutical company, to develop a predictive ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Neuron23® Inc., a clinical-stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological ...

A novel biomarker signature may offer a more objective way of predicting pain sensitivity, new research suggested. Investigators utilized the biomarker, which consisted of two measures — sensorimotor ...

The current standard of care for psychosis is a diagnostic interview, but what if it could be diagnosed before the first symptom emerged? Researchers are pointing toward a potential biomarker in the ...